Current State, Control, Impact and Management of Rheumatoid Arthritis According to Patient : AR 2020 National Survey
Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved..
OBJECTIVES: To analyse current status, control and impact of RA on patients' lives as well as the management of RA symptoms.
METHODS: A structured anonymous online questionnaire was designed and sent to patients with RA, aged 18 years or above living in Spain. Participants were invited though different strategies: 1) ConArtritis and related patients associations; 2) Patients participating in the platform www.in-pacient.es; 3) Links from ConArtritis website and open social networks. Sociodemographic and clinical variables, as well as others related to the objectives were collected. A descriptive analysis was performed.
RESULTS: We analysed 882 RA patients, 89% women, with a median age of 52 years, 31.9% disease duration <5 years. They reported a mean pain and patient global disease score (0-10) of 5.1 and 4.9 respectively. The rate of patients with many difficulties or inability to perform daily tasks varied from 6.4% to 49.2%. Based on the activity index 56.8% of patients reported high activity. We found a great or severe impact on the emotional well-being in 31.5% of patients, and of 29.2% in the workplace or academic setting. A total of 87.9% are taking some medication for RA, and 17.3% are little / not satisfied with them. In addition, 67.1% take conventional synthetic disease modifying drugs (DMARDs), and 45.9% biological therapies including biosimilars and small molecules.
CONCLUSIONS: The current impact of RA on patients' daily lives remains very high. A significant number of patients are not taking DMARDs (conventional synthetic and / or biologics) despite high activity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - year:2020 |
---|---|
Enthalten in: |
Reumatologia clinica - (2020) vom: 26. Nov. |
Sprache: |
Englisch |
---|
Weiterer Titel: |
Estado, control, impacto y manejo actual de la artritis reumatoide según los pacientes: encuesta nacional AR 2020 |
---|
Beteiligte Personen: |
Alcaide, Laly [VerfasserIn] |
---|
Links: |
---|
Themen: |
Artritis reumatoide |
---|
Anmerkungen: |
Date Revised 22.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.reuma.2020.10.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM318167573 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM318167573 | ||
003 | DE-627 | ||
005 | 20240229143007.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.reuma.2020.10.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n1303.xml |
035 | |a (DE-627)NLM318167573 | ||
035 | |a (NLM)33250361 | ||
035 | |a (PII)S1699-258X(20)30243-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Alcaide, Laly |e verfasserin |4 aut | |
245 | 1 | 0 | |a Current State, Control, Impact and Management of Rheumatoid Arthritis According to Patient |b AR 2020 National Survey |
246 | 3 | 3 | |a Estado, control, impacto y manejo actual de la artritis reumatoide según los pacientes: encuesta nacional AR 2020 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 22.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved. | ||
520 | |a OBJECTIVES: To analyse current status, control and impact of RA on patients' lives as well as the management of RA symptoms | ||
520 | |a METHODS: A structured anonymous online questionnaire was designed and sent to patients with RA, aged 18 years or above living in Spain. Participants were invited though different strategies: 1) ConArtritis and related patients associations; 2) Patients participating in the platform www.in-pacient.es; 3) Links from ConArtritis website and open social networks. Sociodemographic and clinical variables, as well as others related to the objectives were collected. A descriptive analysis was performed | ||
520 | |a RESULTS: We analysed 882 RA patients, 89% women, with a median age of 52 years, 31.9% disease duration <5 years. They reported a mean pain and patient global disease score (0-10) of 5.1 and 4.9 respectively. The rate of patients with many difficulties or inability to perform daily tasks varied from 6.4% to 49.2%. Based on the activity index 56.8% of patients reported high activity. We found a great or severe impact on the emotional well-being in 31.5% of patients, and of 29.2% in the workplace or academic setting. A total of 87.9% are taking some medication for RA, and 17.3% are little / not satisfied with them. In addition, 67.1% take conventional synthetic disease modifying drugs (DMARDs), and 45.9% biological therapies including biosimilars and small molecules | ||
520 | |a CONCLUSIONS: The current impact of RA on patients' daily lives remains very high. A significant number of patients are not taking DMARDs (conventional synthetic and / or biologics) despite high activity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Artritis reumatoide | |
650 | 4 | |a Calidad de vida | |
650 | 4 | |a Dolor | |
650 | 4 | |a Encuesta | |
650 | 4 | |a Fatiga | |
650 | 4 | |a Fatigue | |
650 | 4 | |a Pain | |
650 | 4 | |a Quality of life | |
650 | 4 | |a Rheumatoid arthritis | |
650 | 4 | |a Survey | |
650 | 4 | |a Tratamiento | |
650 | 4 | |a Treatment | |
700 | 1 | |a Torralba, Antonio I |e verfasserin |4 aut | |
700 | 1 | |a Eusamio Serre, José |e verfasserin |4 aut | |
700 | 1 | |a García Cotarelo, Carlos |e verfasserin |4 aut | |
700 | 1 | |a Loza, Estíbaliz |e verfasserin |4 aut | |
700 | 1 | |a Sivera, Francisca |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Reumatologia clinica |d 2011 |g (2020) vom: 26. Nov. |w (DE-627)NLM213092891 |x 2173-5743 |7 nnns |
773 | 1 | 8 | |g year:2020 |g day:26 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.reuma.2020.10.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2020 |b 26 |c 11 |